Gilead Sciences, Inc. (GILD) Completes Acquisition of YM BioSciences (YM.TO)
2/11/2013 8:59:55 AM
More...
|
YM BioSciences (YM.TO) Reports Operational and Financial Results for the Second Quarter of Fiscal 2013
2/7/2013 8:06:30 AM
More...
|
YM BioSciences (YM.TO) Announces Receipt of Final Court Order Approving the Plan of Arrangement With Gilead Sciences, Inc. (GILD)
2/5/2013 10:24:38 AM
More...
|
YM BioSciences (YM.TO) Shareholders Approve Plan of Arrangement With Gilead Sciences, Inc. (GILD)
2/1/2013 9:00:09 AM
More...
|
YM BioSciences (YM.TO) Plan of Arrangement With Gilead Sciences, Inc. (GILD) Endorsed by Leading Independent Proxy Advisors ISS and Glass Lewis
1/18/2013 9:05:01 AM
More...
|
YM BioSciences (YM.TO) Announces Record Date for Previously Announced Plan of Arrangement
12/21/2012 11:05:20 AM
More...
|
Gilead Sciences, Inc. (GILD) Bags Blood Disorder Drug With $510 Million YM BioSciences (YM.TO) Buy
12/12/2012 7:24:18 AM
More...
|
YM BioSciences (YM.TO) Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at American Society of Hematology 2012
12/10/2012 9:29:39 AM
More...
|
YM BioSciences (YM.TO) Reports Divestiture of Nimotuzumab Assets by CIMYM
12/4/2012 9:18:35 AM
More...
|
YM BioSciences (YM.TO) Announces Election of Dr. Kapil Dhingra to Its Board of Directors
11/21/2012 8:24:50 AM
More...
|
|